A Novel technology platform for point-of-care immunodiagnostics
MBU group with partners and research institutes of Novosibirsk Scientific Center are developing portable medical devices for Point-of-Care immunodiagnostics. Medical devices are designed and included silica nanowires, which show high capacity, sensitivity and biological compatibility.
Devices and diagnostics chips are designed and adjusted to several formats of point-of-care diagnostics: self-testing, bedside testing, near patient testing and as an express analysis inside the hospital and small diagnostic laboratory.
Developed devices will be compared to current tests in reliability, sensitivity and immediate results to help making treatment decisions more quickly but their cost efficiency is suitable for outside hospital and for low-income settings.Partnership opportunities:
We are looking for companies-manufacturers of integrated microcircuit and microfluidic systems to cooperate on a project.